Archive for the ‘lack of IRB approval’ Category
PLOS ONE has retracted an article it published earlier this year by a group from Australia who failed to receive adequate ethics approval for their study.
The paper, “Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren’s Disease,” came from Warren M. Rozen, Yasith Edirisinghe and John Crock (sorry, irony machine not working today). Dupuytren’s causes thickening of the fascia in the hands and often requires surgery. In 2011 the FDA approved a treatment for the ailment that involves injections of an enzyme — Clostridium Histolyticum Collagenase, or CHC — into the affected area.
The Aussie article looked at the effects of CHC injections in 12 patients over one year, finding that two of the patients suffered Read the rest of this entry »
Another odd retraction for alcohol researcher, this time for lack of animal research committee approval
The journal Neuroscience has retracted a 2011 paper by an alcohol researcher from the United Arab Emirates, who apparently conducted some mouse studies without the blessing of his institution’s animal ethics officials. At least, that’s what the retraction notice would have us believe.
The paper in question, “The pre-synaptic metabotropic glutamate receptor 7 “mGluR7” is a critical modulator of ethanol sensitivity in mice,” by Amine Bahi, was published in December 2011 and cited three times (twice by the author), according to Thomson Scientific’s Web of Knowledge. But as the notice explains:
Chiropractic & Manual Therapies — formerly known as Chiropractic & Osteopathy — has retracted a 2010 paper by a team of Australian researchers who failed to obtain institutional review board (IRB) approval for their studies.
It has been a while since we heard about Joachim Boldt, the German anesthesiologist whose 90-odd retractions briefly put him at the top of the heap until Yoshitaka Fujii kicked him off earlier this year.
Now, Boldt’s former institution, the Klinikum Ludwigshafen, has released a report on its investigation into the disgraced critical care expert, and the results aren’t pretty. Here’s a press release about the report, in its entirety: Read the rest of this entry »
The European Journal of Surgical Oncology has retracted a meeting abstract that evidently was never meant to be.
The study, by researchers at Queen Elizabeth Hospital and Good Hope Hospital, both in Birmingham, England, was to be presented at this year’s annual meeting of the Association of Breast Surgery and purported to compare rates of patient satisfaction among women who underwent two kinds of breast reconstruction, TRAM — transverse rectus abdominis myocutaneous — flap and DIEP (short for deep inferior epigastric perforators) flap.
Does anesthesiology have a problem? Final version of report suggests Fujii will take retraction record, with 172
Japanese investigators have concluded that Yoshitaka Fujii, an expert in postoperative nausea and vomiting whose findings drew scrutiny in 2000 but who continued to publish prolifically for a decade after, fabricated his results in at least 172 published studies.
That number nearly doubles that of the current unofficial retraction record holder, Joachim Boldt.
An inquiry by the Japanese Society of Anesthesiologists (JSA) has determined that Fujii, who was fired in February from his post at Toho University, falsified data in 172 of 212 papers published between 1993 and 2011. Investigators said they found no evidence of fraud in three of the papers, but could not determine whether the results reported in the remaining 37 were reliable.
Of the 172 bogus studies, 126 involved randomized controlled trials. Investigators believe this was not a coincidence: Read the rest of this entry »
Three journals under the JAMA umbrella are retracting papers by Yoshitaka Fujii, the Japanese anesthesiologist accused of research misconduct so sweeping that it might net him the record for most retractions by a single author.
Here are the notices, which are essentially identical but for the titles of the articles: Read the rest of this entry »
PLoS ONE has issued an expression of concern over a 2010 paper by Chinese scientists about how the immune system responds to the vaccine against the swine flu.
The article, “Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine,” claimed to study 58 subjects given the inoculation (more on that below) and that Read the rest of this entry »